ADXS — Ayala Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $24.30m
- $27.23m
- $0.01m
Brief: Advaxis Posts Quarterly Loss Per Share $0.10
U.S. STOCKS ON THE MOVE-Akers Biosciences, Comstock, Virtusa
U.S. STOCKS ON THE MOVE-Akers Biosciences, Comstock, Futu Holdings
Advaxis: Up on positive trial data from combination therapy for lung cancer
Brief: Advaxis Announces Updated Positive Clinical And Biomarker Data From Ongoing Phase 1/2 Adxs-503 Trial In NSCLC
Brief: Advaxis - Entered Into Sales Agreement Pursuant To Which Co May Offer & Sell Up To Aggregate Of $40 Million Of Co's Shares
Brief: Advaxis Says Received Notice That It Is Not In Compliance With Nasdaq Listing Rule
Brief: Advaxis Inc Reports Qtrly Loss Per Share Of $0.15
Nasdaq Trade Halt Market Wide Circuit Breaker Halt: LEVEL 1 AT 08:34 AM
Brief: Advaxis Announces Updated Positive Clinical Data In Ongoing Phase 1/2 ADXS-503 Trial In NSCLC
Brief: Advaxis Announces Positive Clinical Data In Ongoing Phase 1/2 ADXS-503 Trial
U.S. STOCKS ON THE MOVE-Cisco, Tesla, Kraft Heinz, Equifax, Ralph Lauren
U.S. STOCKS ON THE MOVE-Tesla, Kraft Heinz, Equifax, CenturyLink, Ralph Lauren
Brief: Advaxis Announces Updated Survival Data In Phase 1/2 ADXS-PSA Trial
Advaxis rises on promising early-stage data from cancer combo therapy
Brief: Advaxis And Personalis Announce Agreement To Deploy Immunoid Next Platform
Brief: Cvi Investments Inc Reports 8.3% Passive Stake In Advaxis As Of Jan 21
Brief: Advaxis Announces Pricing Of $10.5 Mln Registered Direct Offering
Advaxis slides on direct stock deal